(Q36422772)

English

Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1 reference

based on heuristic

inferred from title

11

object named as

Mella O

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Steinar Lundgren

9

object named as

Lundgren S

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Tadeusz Pieńkowski

5

object named as

Pienkowski T

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Pyrhönen S

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Valavaara R

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Modig H

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Pawlicki M

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Gundersen S

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Bauer J

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Westman G

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Blanco G

10

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Nilsson I

12

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Hietanen T

13

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Hindy I

14

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Vuorinen J

15

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Hajba A

16

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

1 January 1997

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

76

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

270-277

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

30 September 2017

Use of tamoxifen for breast cancer: twenty-eight years later

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

30 September 2017

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

30 September 2017

Sex hormones and neoplasia: liver tumors in rodents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

30 September 2017

Endocrine treatment of breast cancer in women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

30 September 2017

Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

30 September 2017

Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

30 September 2017

Agonistic and antagonistic effects of antiestrogens in different target organs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

30 September 2017

A two-year dietary carcinogenicity study of the antiestrogen toremifene in Sprague-Dawley rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

Tamoxifen induces hepatocellular carcinoma in rat liver: a 1-year study with two antiestrogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

Diethylstilbestrol liver carcinogenicity and modification of DNA in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by tamoxifen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

A new triphenylethylene compound, Fc-1157a. II. Antitumor effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

High dose toremifene (240 mg daily) is effective as first line hormonal treatment in advanced breast cancer. An ongoing phase II multicenter Finnish-Latvian cooperative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

Treatment of advanced breast cancer with 20 mg toremifene, a phase II study. Preliminary communication.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

Induction of covalent DNA adducts in rodents by tamoxifen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223944

28 June 2018

[Phase II study of NK 622 (toremifene citrate) in advanced breast cancer, a multicentral cooperative dose finding study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for ocular toxicity in asymptomatic patients treated with tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new triphenylethylene compound, Fc-1157a. I. Hormonal effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the c-Ha-ras andneu oncogenes in DMBA-induced, anti-estrogen-treated rat mammary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of toremifene on clinical chemistry, hematology and hormone levels at different doses in healthy postmenopausal volunteers: phase I study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of toremifene in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicentric breast tumour: an anatomical-clinical study of 100 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose toremifene in advanced breast cancer resistant to or relapsed during tamoxifen treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of DNA reactivity of the polyphenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9231932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1997.375

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

release_kkk42m2pezezndztny36v67vke

1 reference

https://api.fatcat.wiki/v0/release/kkk42m2pezezndztny36v67vke

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36422772&oldid=2198869813"